Actively Recruiting
ST250 as a Therapeutic Option for Head & Neck Reconstruction
Led by Alaa Emara · Updated on 2025-05-18
60
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To assess the use of SupraThel 250 for mucosal reconstruction in the Head \& Neck region. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing
CONDITIONS
Official Title
ST250 as a Therapeutic Option for Head & Neck Reconstruction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Recurrent episodes of tonsillar infection
- Age 18 years or older
You will not qualify if you...
- Children
- Pregnant or breastfeeding women
- Patients undergoing chemotherapy or radiotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MarienHospital
Stuttgart, Baden-Wurttemberg, Germany, 71638
Actively Recruiting
Research Team
A
Alaa Emara
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here